Tanvex BioPharma Correlations
| 6541 Stock | TWD 72.00 0.30 0.41% |
The current 90-days correlation between Tanvex BioPharma and Great Taipei Gas is 0.12 (i.e., Average diversification). The correlation of Tanvex BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Tanvex BioPharma Correlation With Market
Average diversification
The correlation between Tanvex BioPharma and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and DJI in the same portfolio, assuming nothing else is changed.
Tanvex |
The ability to find closely correlated positions to Tanvex BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tanvex BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tanvex BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tanvex BioPharma to buy it.
Moving together with Tanvex Stock
| 0.65 | 4174 | OBI Pharma | PairCorr |
| 0.68 | 2888 | Shin Kong Financial | PairCorr |
| 0.64 | 2888A | Shin Kong Financial | PairCorr |
Moving against Tanvex Stock
| 0.71 | 4162 | PharmaEngine | PairCorr |
| 0.71 | 2317 | Hon Hai Precision | PairCorr |
| 0.69 | 2330 | Taiwan Semiconductor | PairCorr |
| 0.65 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.64 | 0053 | YuantaP shares Taiwan | PairCorr |
| 0.61 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.54 | 2882B | Cathay Financial Holding | PairCorr |
| 0.52 | 2881A | Fubon Financial Holding | PairCorr |
| 0.49 | 2891 | CTBC Financial Holding | PairCorr |
| 0.45 | 2883 | China Development | PairCorr |
| 0.44 | 6589 | EirGenix | PairCorr |
| 0.35 | 2882A | Cathay Financial Holding | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tanvex Stock performing well and Tanvex BioPharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tanvex BioPharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6438 | 2.74 | 0.77 | 0.24 | 4.41 | 2.02 | 9.79 | 17.42 | |||
| 5245 | 1.57 | (0.15) | 0.00 | (16.11) | 0.00 | 2.89 | 16.35 | |||
| 3034 | 1.11 | (0.22) | 0.00 | (0.73) | 0.00 | 1.97 | 8.21 | |||
| 3058 | 1.71 | 0.03 | 0.00 | 0.04 | 0.00 | 2.98 | 15.92 | |||
| 6697 | 1.23 | (0.01) | (0.04) | 0.08 | 1.71 | 2.33 | 15.29 | |||
| 6209 | 1.08 | (0.18) | 0.00 | (0.53) | 0.00 | 1.98 | 5.38 | |||
| 9921 | 1.66 | (0.70) | 0.00 | (2.69) | 0.00 | 1.99 | 14.43 | |||
| 2395 | 1.16 | (0.08) | (0.06) | (0.01) | 1.76 | 2.71 | 7.98 | |||
| 2882A | 0.09 | 0.00 | (0.55) | 0.24 | 0.00 | 0.33 | 0.82 | |||
| 9908 | 0.19 | (0.05) | 0.00 | (0.74) | 0.00 | 0.33 | 1.16 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tanvex BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Tanvex BioPharma Corporate Management
Elected by the shareholders, the Tanvex BioPharma's board of directors comprises two types of representatives: Tanvex BioPharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tanvex. The board's role is to monitor Tanvex BioPharma's management team and ensure that shareholders' interests are well served. Tanvex BioPharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tanvex BioPharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Val Chen | Director Officer | Profile | |
| Helena Makagiansar | Deputy General Manager-LJB Production Development | Profile | |
| Yongjian Wu | Deputy General Manager-LJB Research & Development | Profile | |
| LungYeh Cho | Director | Profile | |
| Dilip Joshi | VP US | Profile | |
| LeeChiou Chang | Independent Director | Profile |